Procedures such as apheresis, or ‘blood washing’, and anti-clotting therapy are being offered in Europe
Thousands of people with long Covid are travelling abroad to spend huge sums of money on unproven treatments such as “blood washing”, prompting warnings from experts and doctor
Gymnema sylvestre is a woody climbing shrub that’s native to the tropical forests of India, Africa and Australia.
Its leaves have been used in the ancient Indian medicinal practice Ayurveda for thousands of years.
It has been a traditional remedy for various ailments, including d
Many people with diabetes use insulin syringes (often multiple times a day) to administer the insulin dose prescribed by their treating doctor. While in type 1 diabetes, the body can’t make its own insulin to regulate blood sugar levels, in type 2 diabetes, the body can’t use insulin effic
Subscribe to our Daily Headlines newsletter.
The first insulin shots for diabetes were administered by a doctor in 1922. Today people living with diabetes can give themselves shots or use a pump. Odds are high that the syringes people use for diabetes are manufactured in Holdrege.
Growth in demand for syringes requires a faster production process.
Demand for pharma packaging products vastly increased following the COVID crisis, requiring an accelerated production process. This includes faster inspection and packing without negatively impact on quality, a factor of
After first discussing the matter almost a month ago, Haywood County commissioners are now calling upon the General Assembly to allow North Carolina counties to regulate third-party syringe service programs.
“This is a resolution that attempts to address the issue that had been raised
FREE Breaking News Alerts from StreetInsider.com!
PRINCETON, N.J. , Oct. 6, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader specializing in blood purification, announced today that the U.S. Army Medical Research Acquisition Activity (
SAN DIEGO, CA, Oct. 06, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage company focused on creating therapeutic solutions to address unmet needs in global health, today announced that a provisional pat
Separate curriculum for minorities likely
Global healthcare firm enters Pakistan
EU funds equipment to enhance capacity of public healthcare facility
As part of a concerted effort to strengthen the delivery of health services in Sindh, the United Nations High Commissioner fo
Permanent link to this press release:
Delete press release Edit press rele